Non-selectivity of new bradykinin antagonists for B1 receptors.
N E Rhaleb, F Gobeil, D Regoli
Index: Life Sci. 51 , PL 125, (1992)
Full Text: HTML
Abstract
Two new B1 receptor antagonists, [Hyp3,Thi5,DTic7,Oic8]desArg9-BK and DArg[Hyp3,Thi5,DTic7,Oic8]desArg9-BK were tested in vitro on the rabbit jugular vein and the guinea pig ileum (preparations containing B2 receptors) and on the rabbit aorta (preparation containing B1 receptors) for pharmacological characterization. The results indicate that both compounds are antagonists on both B1 and B2 receptors, are competitive and discriminate between B2A and B2B receptor subtypes.
Related Compounds
Related Articles:
New highly potent bradykinin B2 receptor antagonists.
1991-09-01
[Agents Actions 34 , 138-141, (1991)]
1992-05-01
[J. Med. Chem. 35 , 1563, (1992)]
Pharmacological evidence for a single bradykinin B2 receptor in the guinea-pig.
1995-10-01
[Br. J. Pharmacol. 116(3) , 2106-12, (1995)]
1992-01-14
[Eur. J. Pharmacol. 210(2) , 115-20, (1992)]